NETTI Wheelchair: Does Dynamic Mode or Static Mode Affect the Sitting Position in Patients with Involuntary Movements ?

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Apr 2, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how two different modes of the NETTI wheelchair—dynamic mode and static mode—affect the comfort and sitting position of patients who experience involuntary movements, such as hyperextension spasms. The aim is to find out which mode helps these patients feel more comfortable while sitting in their wheelchair. Participants will take part in a study where they will use both modes of the chair at different times and compare their experiences.

To be eligible for the trial, participants should be at least 16 years old and experience involuntary movements that happen more than three times an hour, requiring them to adjust their position in the wheelchair at least every two hours. They should also be able to sit in a wheelchair for at least four hours a day. Participants will be asked to provide informed consent, meaning they agree to take part in the study with a full understanding of what it involves. If you or a loved one is interested in participating, please know that this study will help researchers learn more about how to improve comfort for people with similar conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient with involuntary extension movements with a frequency greater than (\>) 3/hour and requiring at least one wheelchair repositioning every 2 hours.
• • Patient using a wheelchair and requiring to be in a seated position at least 4 hours per day.
• • Patient and/or representative with free and informed consent.
• • Patient and/or representative having signed the consent form.
• • Patient affiliated or beneficiary of a health insurance plan.
• • Patient over 16 years of age (≥16 years).
• Exclusion Criteria:
• • Patient unable to sit in chair for at least 3 hours a day.
• • Patient unable to sit in the chair without the use of a thermoformed corset.
• • Patients weighing over 135kg.
• • Patient participating in a drug study.
• • Patient in an exclusion period determined by another study.
• • Patient/legal representative for whom it is impossible to provide informed information.
• • Pregnant or breast-feeding patient